Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

NMTR 9 Meters Biopharma Inc

0.0722

0.00 (0.00%)

After Hours

Last Updated: 20:00:00

Delayed by 15 minutes

9 meters launches Phase 2 VIBRANT study of vurolenatide for short bowel syndrome

To read the full story on Seeking Alpha, click here.

9 Meters Biopharma (NASDAQ:NMTR)
Historical Stock Chart
From May 2024 to Jun 2024

Click Here for more 9 Meters Biopharma Charts.

9 Meters Biopharma (NASDAQ:NMTR)
Historical Stock Chart
From Jun 2023 to Jun 2024

Click Here for more 9 Meters Biopharma Charts.

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Share on Facebook Share on Twitter Share on Email

Loading Messages....

See More Message Board Posts

9 Meters Biopharma Inc News

More 9 Meters Biopharma Inc News Articles

Decentral Life (PK)

GNCC Capital (CE)

Impact Fusion (PK)

Enzolytics (PK)

Iovance Biotherapeutics

AMC Entertainment

Voip Pal Com (QB)

Marketing Worldwide (PK)

Kraig Biocraft Laborator... (QB)

Ubiquitech Software (PK)

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions